Is GBL legal in France?
- Legal status
- Part of the stupéfiants (narcotics) regime is applied to GBL (gamma-butyrolactone) by the Arrêté du 2 septembre 2011 under the Code de la santé publique: the offer and cession to the public of GBL and 1,4-BD — and of products containing them above 10% m/v in containers over 100 ml — are prohibited, while industrial and professional supply is retained (GHB itself has been a stupéfiant since 1999).
- Consequences if caught
- Selling or transferring GBL to the public breaches the arrêté and carries up to 3 years' imprisonment and a EUR 45,000 fine; personal misuse as a GHB prodrug is addressed within the narcotics framework.
- If prescribed or medical
- Not a medicine; there is no GBL pharmaceutical product. It remains a licit industrial solvent — professional and industrial transactions stay lawful, and only retail-to-public sale and high-concentration consumer products are banned.
- Documentation
- GBL stays available through professional and industrial channels; consumer and online sale for ingestion is criminalised, closing the retail route while preserving the industrial carve-out.
Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with France’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately — not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →